Published in Mol Cell Biol on June 01, 2000
A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Natl Acad Sci U S A (2002) 2.78
Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol (2003) 1.92
Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep (2000) 1.76
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Nuclear functions of the HMG proteins. Biochim Biophys Acta (2009) 1.63
Priming the nucleosome: a role for HMGB proteins? EMBO Rep (2003) 1.62
Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci (2010) 1.39
HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab (2010) 1.39
Effects of nucleoid proteins on DNA repression loop formation in Escherichia coli. Nucleic Acids Res (2007) 1.31
The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly. Mol Cell Biol (2002) 1.20
High-mobility group protein box-1 and its relevance to cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.16
Fine structure and activity of discrete RAG-HMG complexes on V(D)J recombination signals. Mol Cell Biol (2002) 1.15
High-mobility-group proteins NHP6A and NHP6B participate in activation of the RNA polymerase III SNR6 gene. Mol Cell Biol (2001) 1.09
The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity. Nucleic Acids Res (2003) 1.07
Understanding apparent DNA flexibility enhancement by HU and HMGB architectural proteins. J Mol Biol (2011) 1.00
Determinants of HMGB proteins required to promote RAG1/2-recombination signal sequence complex assembly and catalysis during V(D)J recombination. Mol Cell Biol (2005) 0.98
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res (2008) 0.94
Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders. Front Behav Neurosci (2015) 0.93
Enhancement of DNA flexibility in vitro and in vivo by HMGB box A proteins carrying box B residues. Biochemistry (2009) 0.90
Transient HMGB protein interactions with B-DNA duplexes and complexes. Biochem Biophys Res Commun (2008) 0.90
The DNA architectural protein HMGB1 facilitates RTA-mediated viral gene expression in gamma-2 herpesviruses. J Virol (2004) 0.88
Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending. PLoS One (2013) 0.85
Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J (2001) 0.84
Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol (2011) 0.83
Nucleosome dynamics: HMGB1 relaxes canonical nucleosome structure to facilitate estrogen receptor binding. Nucleic Acids Res (2012) 0.83
The role of response elements organization in transcription factor selectivity: the IFN-β enhanceosome example. PLoS Comput Biol (2011) 0.82
Basic N-terminus of yeast Nhp6A regulates the mechanism of its DNA flexibility enhancement. J Mol Biol (2011) 0.80
High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochir Suppl (2013) 0.80
Mitochondrial Translocation of High Mobility Group Box 1 Facilitates LIM Kinase 2-Mediated Programmed Necrotic Neuronal Death. Front Cell Neurosci (2016) 0.78
Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci Rep (2017) 0.75
Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science (1989) 8.98
The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell (1992) 6.47
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet (1994) 5.43
A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol (1988) 5.28
Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol (1999) 4.91
Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev (1995) 4.34
High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol (1996) 4.22
Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol (1990) 4.09
Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature (1995) 4.08
lac repressor forms loops with linear DNA carrying two suitably spaced lac operators. EMBO J (1987) 4.02
The enhanceosome and transcriptional synergy. Cell (1998) 3.93
Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol (1998) 3.81
Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature (1995) 3.58
trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol (1992) 3.22
DNA sequence determinants of CAP-induced bending and protein binding affinity. Nature (1988) 3.22
The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev (1993) 3.01
Structure of the HMG box motif in the B-domain of HMG1. EMBO J (1993) 2.84
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48
High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev (1998) 2.40
High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol (1998) 2.38
Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J (1997) 2.35
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature (1999) 2.35
A general mechanism for transcriptional synergy by eukaryotic activators. Nature (1995) 2.29
Detection of localized DNA flexibility. Nature (1994) 2.18
Action at a distance along a DNA. Science (1988) 2.13
HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. EMBO J (1996) 2.09
The structure of a chromosomal high mobility group protein-DNA complex reveals sequence-neutral mechanisms important for non-sequence-specific DNA recognition. EMBO J (1999) 1.91
Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res (1993) 1.83
Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol (1991) 1.79
HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol (1999) 1.71
Nucleosome structure completely inhibits in vitro cleavage by the V(D)J recombinase. EMBO J (1999) 1.66
Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes in vitro. Genes Dev (1996) 1.66
Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. EMBO J (1999) 1.63
The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol Cell Biol (1999) 1.61
Higher-order nucleoprotein complexes in transcription: analogies with site-specific recombination. Curr Opin Cell Biol (1995) 1.59
Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry (1995) 1.43
DNA looping and the helical repeat in vitro and in vivo: effect of HU protein and enhancer location on Hin invertasome assembly. EMBO J (1993) 1.42
The ZEBRA activation domain: modular organization and mechanism of action. Mol Cell Biol (1993) 1.33
DNA curvature and deformation in protein-DNA complexes: a step in the right direction. Proc Natl Acad Sci U S A (1998) 1.32
Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem (1999) 1.32
A heteroduplex template circumvents the energetic requirement for ATP during activated transcription by RNA polymerase II. J Biol Chem (1994) 1.31
HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol (1999) 1.31
DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J Biol Chem (1998) 1.23
Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids (1999) 1.15
Differences in the DNA-binding properties of the HMG-box domains of HMG1 and the sex-determining factor SRY. Eur J Biochem (1995) 1.13
Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain. J Mol Biol (1999) 1.12
HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J (1995) 1.10
DNA-binding properties of the tandem HMG boxes of high-mobility-group protein 1 (HMG1). Eur J Biochem (1998) 1.08
V(D)J recombination: on the cutting edge. Curr Opin Cell Biol (1999) 1.04
Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly. Mol Cell Biol (1999) 1.02
High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation. Mol Endocrinol (1997) 1.01
Imposing specificity by localization: mechanism and evolvability Curr Biol (1998) 0.95
Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein. Biochemistry (1999) 0.92
Increased DNA-bending activity and higher affinity DNA binding of high mobility group protein HMG-1 prepared without acids. J Biol Chem (1995) 0.85
Transforming functions associated with Epstein-Barr virus. J Invest Dermatol (1984) 0.84
Domain-domain interactions in high mobility group 1 protein (HMG1). Eur J Biochem (1999) 0.83
Cooperative assembly of RNA polymerase II transcription complexes. Cold Spring Harb Symp Quant Biol (1998) 0.82
The stabilized structural array of two HMG1/2-boxes endowed by a linker sequence between them is requisite for the effective binding of HMG1 with DNA. J Biochem (1999) 0.81
Differentiation of pathogenic and saprophytic letospires. I. Growth at low temperatures. J Bacteriol (1967) 8.91
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell (1993) 6.05
DNA recognition by GAL4: structure of a protein-DNA complex. Nature (1992) 5.60
Infection of Syrian hamsters with Lyme disease spirochetes. J Clin Microbiol (1984) 5.40
Isolation of spontaneously derived mutants of Caulobacter crescentus. Genetics (1977) 4.44
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med (1999) 4.20
Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis (1987) 3.79
Genetic relationship of lyme disease spirochetes to Borrelia, Treponema, and Leptospira spp. J Clin Microbiol (1984) 3.78
Hin-mediated site-specific recombination requires two 26 bp recombination sites and a 60 bp recombinational enhancer. Cell (1985) 3.69
Generalized Transduction in CAULOBACTER CRESCENTUS. Genetics (1977) 3.62
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol (1995) 3.59
Dramatic changes in Fis levels upon nutrient upshift in Escherichia coli. J Bacteriol (1992) 3.39
Retention of motility and virulence of Treponema pallidum (Nichols strain) in vitro. Infect Immun (1975) 3.31
Host protein requirements for in vitro site-specific DNA inversion. Cell (1986) 3.31
Identification of endemic foci of Lyme disease: isolation of Borrelia burgdorferi from feral rodents and ticks (Dermacentor variabilis). J Clin Microbiol (1985) 3.17
The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies. JAMA (1993) 3.09
The Fis protein: it's not just for DNA inversion anymore. Mol Microbiol (1992) 3.02
The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev (1993) 3.01
Characterization of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells and the potential relationship of attachment to pathogenicity. Infect Immun (1977) 2.95
How different eukaryotic transcriptional activators can cooperate promiscuously. Nature (1990) 2.91
Analysis of nonmotile mutants of the dimorphic bacterium Caulobacter crescentus. J Bacteriol (1979) 2.75
Control of Tn5 transposition in Escherichia coli is mediated by protein from the right repeat. Cell (1982) 2.74
Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry (1998) 2.69
Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol (1990) 2.60
Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med (1996) 2.58
Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun (1986) 2.55
The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron (2001) 2.52
Polymerase II promoter activation: closed complex formation and ATP-driven start site opening. Science (1992) 2.42
Involvement of birds in the epidemiology of the Lyme disease agent Borrelia burgdorferi. Infect Immun (1986) 2.40
Antileptospiral activity of serum. I. Normal and immune serum. J Bacteriol (1966) 2.38
Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A (1995) 2.37
The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med (1994) 2.36
Interaction of Treponema pallidum (Nichols strain) with cultured mammalian cells: effects of oxygen, reducing agents, serum supplements, and different cell types. Infect Immun (1977) 2.33
Isolation of the outer envelope, chemical components, and ultrastructure of Borrelia hermsi grown in vitro. Acta Trop (1979) 2.33
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
DNA sequences at the ends of transposon Tn5 required for transposition. Nature (1983) 2.32
The rational clinical examination. Does this patient have strep throat? JAMA (2000) 2.30
A general mechanism for transcriptional synergy by eukaryotic activators. Nature (1995) 2.29
Surface mucopolysaccharides of Treponema pallidum. Infect Immun (1979) 2.27
Isolation of the outer sheath of Leptospira and its immunogenic properties in hamsters. Infect Immun (1972) 2.20
Antigenically variable Borrelia burgdorferi isolated from cottontail rabbits and Ixodes dentatus in rural and urban areas. J Clin Microbiol (1989) 2.20
Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells. J Bacteriol (1977) 2.19
Genetic organization of Tn5. Cold Spring Harb Symp Quant Biol (1981) 2.18
Treatment of early Lyme disease. Am J Med (1992) 2.18
The histopathology of experimentally infected hamsters with the Lyme disease spirochete, Borrelia burgdorferi. Proc Soc Exp Biol Med (1986) 2.18
The spirochetes. Annu Rev Microbiol (1977) 2.18
Efficient excision of phage lambda from the Escherichia coli chromosome requires the Fis protein. J Bacteriol (1991) 2.16
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol (1992) 2.12
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro. Mol Cell Biol (1989) 2.06
The Hin invertasome: protein-mediated joining of distant recombination sites at the enhancer. Science (1990) 2.06
Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North Carolina. J Wildl Dis (1986) 2.04
Fis binding to the recombinational enhancer of the Hin DNA inversion system. Genes Dev (1987) 2.02
Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect Immun (1996) 2.01
Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells. Nature (1985) 1.98
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother (1987) 1.98
Identification of two functional regions in Fis: the N-terminus is required to promote Hin-mediated DNA inversion but not lambda excision. EMBO J (1991) 1.97
Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect Immun (1988) 1.97
A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med (1996) 1.96
Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A (1979) 1.96
Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun (1986) 1.94
The molecular structure of wild-type and a mutant Fis protein: relationship between mutational changes and recombinational enhancer function or DNA binding. Proc Natl Acad Sci U S A (1991) 1.93
Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol (1999) 1.93
Antileptospiral activity of serum. II. Leptospiral virulence factor. J Bacteriol (1967) 1.92
The acidic activator GAL4-AH can stimulate polymerase II transcription by promoting assembly of a closed complex requiring TFIID and TFIIA. Genes Dev (1992) 1.89
Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A (2001) 1.85
Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol Cell Biol (1997) 1.83
Hin recombinase bound to DNA: the origin of specificity in major and minor groove interactions. Science (1994) 1.83
Characterization of Borrelia burgdorferi isolates by restriction endonuclease analysis and DNA hybridization. J Clin Microbiol (1989) 1.83
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
Recognition of streptococcal pharyngitis in adults. Arch Intern Med (1975) 1.81
Role of the IS50 R proteins in the promotion and control of Tn5 transposition. J Mol Biol (1984) 1.79
Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect Immun (1993) 1.79
Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res (1995) 1.77
The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesia. Anesth Analg (2000) 1.77
The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA. EMBO J (1995) 1.77
Lipids of the Spirochaetales: comparison of the lipids of several members of the genera Spirochaeta, Treponema, and Leptospira. J Bacteriol (1974) 1.77
Assembly of the isomerized TFIIA--TFIID--TATA ternary complex is necessary and sufficient for gene activation. Genes Dev (1996) 1.76
Variable structures of Fis-DNA complexes determined by flanking DNA-protein contacts. J Mol Biol (1996) 1.74
Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med (1995) 1.74
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73
Copy number control of Tn5 transposition. Genetics (1984) 1.70
Flagellar hook and basal complex of Caulobacter crescentus. J Bacteriol (1979) 1.69
Characterization of leptospires according to fatty acid requirements. J Gen Microbiol (1969) 1.69
Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes in vitro. Genes Dev (1996) 1.66
Colony formation and morphology in Borrelia burgdorferi. J Clin Microbiol (1987) 1.66
Cultivation of parasitic leptospires: effect of pyruvate. Appl Microbiol (1973) 1.65
Defects in hemostasis in P-selectin-deficient mice. Blood (1996) 1.64
Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. EMBO J (1999) 1.63
Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun (1991) 1.63
DNA analysis of Borrelia burgdorferi NCH-1, the first northcentral U.S. human Lyme disease isolate. J Clin Microbiol (1992) 1.61
Borrelia lymphocytoma: a possible North American case. Wis Med J (1990) 1.61
Characterization of a circular plasmid from Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol (1988) 1.60
Amino acid biosynthesis in the spirochete Leptospira: evidence for a novel pathway of isoleucine biosynthesis. J Bacteriol (1974) 1.60
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination. Clin Infect Dis (1999) 1.59
Sequence, regulation, and functions of fis in Salmonella typhimurium. J Bacteriol (1995) 1.59
Genetic analysis of Borrelia. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 1.59
Treponeme outer cell envelope: solubilization and reaggregation. Infect Immun (1973) 1.58